Literature DB >> 2875757

Low dose maintenance medication for schizophrenia.

R Manchanda, S R Hirsch.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2875757      PMCID: PMC1341296          DOI: 10.1136/bmj.293.6546.515

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  10 in total

1.  Temporal effects of drug and placebo in delaying relapse in schizophrenic outpatients.

Authors:  G E Hogarty; R F Ulrich
Journal:  Arch Gen Psychiatry       Date:  1977-03

2.  Depot neuroleptics: the relevance of psychosocial factors--a United States perspective.

Authors:  G E Hogarty
Journal:  J Clin Psychiatry       Date:  1984-05       Impact factor: 4.384

3.  What is the best maintenance dose of neuroleptics in schizophrenia?

Authors:  R J Baldessarini; J M Davis
Journal:  Psychiatry Res       Date:  1980-10       Impact factor: 3.222

4.  Further observations on the duration of depot neuroleptic maintenance therapy in schizophrenia.

Authors:  D A Johnson
Journal:  Br J Psychiatry       Date:  1979-12       Impact factor: 9.319

5.  Selection of neuroleptic dosage.

Authors:  M H Teicher; R J Baldessarini
Journal:  Arch Gen Psychiatry       Date:  1985-06

6.  Costs and benefits of two doses of fluphenazine.

Authors:  S R Marder; T Van Putten; J Mintz; J McKenzie; M Lebell; G Faltico; P R May
Journal:  Arch Gen Psychiatry       Date:  1984-11

7.  Outpatient maintenance of chronic schizophrenic patients with long-acting fluphenazine: double-blind placebo trial. Report to the Medical Research Council Committee on Clinical Trials in Psychiatry.

Authors:  S R Hirsch; R Gaind; P D Rohde; B C Stevens; J K Wing
Journal:  Br Med J       Date:  1973-03-17

8.  The discontinuance of maintenance neuroleptic therapy in chronic schizophrenic patients: drug and social consequences.

Authors:  D A Johnson; G Pasterski; J M Ludlow; K Street; R D Taylor
Journal:  Acta Psychiatr Scand       Date:  1983-05       Impact factor: 6.392

Review 9.  Antipsychotic medication: clinical guidelines for maintenance therapy.

Authors:  D A Johnson
Journal:  J Clin Psychiatry       Date:  1985-05       Impact factor: 4.384

10.  Low-dose neuroleptic treatment of outpatient schizophrenics. I. Preliminary results for relapse rates.

Authors:  J M Kane; A Rifkin; M Woerner; G Reardon; S Sarantakos; D Schiebel; J Ramos-Lorenzi
Journal:  Arch Gen Psychiatry       Date:  1983-08
  10 in total
  2 in total

1.  Psychotropic drugs.

Authors:  J B Loudon
Journal:  Br Med J (Clin Res Ed)       Date:  1987-01-17

Review 2.  Long-term depot antipsychotics. A risk-benefit assessment.

Authors:  T R Barnes; D A Curson
Journal:  Drug Saf       Date:  1994-06       Impact factor: 5.606

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.